Credit Suisse Ag Uni Qure N.V. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$6.71 - $11.83 $49,674 - $87,577	-7,403 Reduced 8.83%	76,401 $512,000
Q2 2023 Aug 11, 2023	BUY	$11.12 - $22.2 $203,484 - $406,237	18,299 Added 27.94%	83,804 $960,000
Q1 2023 May 10, 2023	BUY	$18.7 - $23.07 $93,126 - $114,888	4,980 Added 8.23%	65,505 $1.32 Million
Q4 2022 Feb 13, 2023	BUY	$18.12 - $27.32 $216,262 - $326,064	11,935 Added 24.56%	60,525 $1.37 Million
Q3 2022 Nov 10, 2022	BUY	$16.98 - $25.54 $323,027 - $485,872	19,024 Added 64.34%	48,590 $911,000
Q2 2022 Aug 12, 2022	BUY	$13.15 - $20.45 $40,107 - $62,372	3,050 Added 11.5%	29,566 $551,000
Q1 2022 May 16, 2022	BUY	$14.54 - $21.5 $17,491 - $25,864	1,203 Added 4.75%	26,516 $480,000
Q4 2021 Feb 14, 2022	SELL	$20.24 - $36.01 $157,386 - $280,013	-7,776 Reduced 23.5%	25,313 $526,000
Q3 2021 Nov 12, 2021	SELL	$26.01 - $38.22 $8.26 Million - $12.1 Million	-317,630 Reduced 90.57%	33,089 $1.06 Million
Q2 2021 Aug 16, 2021	BUY	$29.97 - $37.17 $7.81 Million - $9.69 Million	260,620 Added 289.26%	350,719 $10.8 Million
Q1 2021 May 14, 2021	BUY	$29.24 - $42.03 $824,158 - $1.18 Million	28,186 Added 45.53%	90,099 $3.03 Million
Q4 2020 Feb 12, 2021	BUY	$35.35 - $50.67 $989,800 - $1.42 Million	28,000 Added 82.56%	61,913 $2.24 Million
Q3 2020 Nov 13, 2020	SELL	$35.98 - $47.66 $23,243 - $30,788	-646 Reduced 1.87%	33,913 $1.25 Million
Q2 2020 Aug 12, 2020	BUY	$45.06 - $67.74 $97,825 - $147,063	2,171 Added 6.7%	34,559 $1.56 Million
Q1 2020 May 13, 2020	BUY	$40.01 - $73.97 $557,099 - $1.03 Million	13,924 Added 75.41%	32,388 $1.54 Million
Q4 2019 Feb 12, 2020	SELL	$37.13 - $74.62 $2.14 Million - $4.31 Million	-57,704 Reduced 75.76%	18,464 $1.32 Million
Q3 2019 Nov 12, 2019	BUY	$39.36 - $76.8 $1.95 Million - $3.81 Million	49,609 Added 186.79%	76,168 $3 Million
Q2 2019 Aug 14, 2019	BUY	$52.76 - $82.19 $391,320 - $609,603	7,417 Added 38.75%	26,559 $2.08 Million
Q1 2019 May 14, 2019	BUY	$27.39 - $68.41 $55,218 - $137,914	2,016 Added 11.77%	19,142 $1.14 Million
Q4 2018 Feb 13, 2019	SELL	$22.8 - $33.93 $254,106 - $378,149	-11,145 Reduced 39.42%	17,126 $493,000
Q3 2018 Nov 13, 2018	BUY	$29.75 - $43.08 $144,555 - $209,325	4,859 Added 20.75%	28,271 $1.03 Million
Q2 2018 Aug 14, 2018	BUY	$21.96 - $39.94 $514,127 - $935,075	23,412 New	23,412 $884,000

Others Institutions Holding QURE

# of Institutions

153

Shares Held

41M

Call Options Held

925K

Put Options Held

617K

Vestal Point Capital, LP New York, NY

4.75M
Shares

$27.1 Million
1.78% of portfolio
Nantahala Capital Management, LLC New Canaan, CT

2.78M
Shares

$15.9 Million
0.81% of portfolio
Boxer Capital, LLC San Diego, CA

2.23M
Shares

$12.7 Million
0.58% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

2.19M
Shares

$12.5 Million
0.01% of portfolio
Abrdn PLC

1.93M
Shares

$11 Million
0.02% of portfolio

View Full List

About uniQure N.V.

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $266M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

More about QURE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account